UBS Adjusts Main Street Capital Price Target to $57 From $62, Maintains Neutral Rating

MT newswire2026/10/09 13:54

09:54 AM EDT, 10/09/2026 (MT Newswires) -- Main Street Capital (MAIN) has an average rating of overweight and mean price target of $59.83, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us) Price: 54.33, Change: -0.14, Percent Change: -0.26

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

BUZZ-Vertex Pharmaceuticals shares rise after raising 2026 revenue forecast

路透社•2026/11/02 22:21

Tenuis: Apple achieves growth in most markets in the fourth fiscal quarter

Chaincatcher•2026/11/02 22:19

Palantir's Q3 revenue doubles, U.S. commercial income surpasses government income for the first time, full-year guidance significantly raised | Earnings Report Insights

Palantir’s Q3 revenue reached $2.313 billion, marking a 96% year-on-year increase and surpassing the market expectation of $2.18 billion. U.S. commercial revenue stood at $984 million, soaring 148% year-on-year and exceeding the expected $937 million. For the first time, it surpassed U.S. government revenue, which was $953 million. Adjusted earnings per share were $0.44, higher than the estimated $0.41. The company raised its full-year revenue forecast to between $8.53 billion and $8.534 billion, above the market consensus of $8.2 billion.

华尔街见闻•2026/11/02 22:13

BUZZ-BioMarin Pharma shares fall after lowering annual performance expectations

路透社•2026/11/02 22:06